Nutex Health Inc

Nutex Health Inc (NUTX) Stock Analysis

$186.100

-13.623 (-7.32%)At close

Loading chart…
High
200.500
Open
200.500
VWAP
190.69
Volume
121.21K
Mkt Cap
29.33M
Low
185.460
Amount
23.11M
EV/EBITDA, TTM
2.63

Nutex Health Inc. is a healthcare management and operations company. The Company operates in three segments: the Hospital division, the Population Health Management (PHM) division, and the Real Estate division. The Hospital division owns, develops and operates healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates over 27 facilities in 12 states. In addition, it has financial and operating relationships with multiple professional entities and real estate entities. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). Through its Management Services Organization, it provides management, administrative and other support services to its affiliated hospitals and physician groups. The Real Estate division comprises the Real Estate Entities, which owns the land and hospital buildings which are leased to its hospital entities.

AI analysis of Nutex Health Inc (NUTX)

Buy

Nutex Health Inc is a good buy right now due to its strong recent performance, including a net income of $65.8 million in Q2 2026 and an EPS of $9.38, which is a substantial improvement from a loss in the same quarter last year. The current price is $186.10, and analysts have set price targets as high as $325, suggesting an upside of over 74%. However, the company is facing risks from a recent cybersecurity incident that could impact investor confidence, which is a significant concern.

Valuation Metrics

The current forward P/E ratio for Nutex Health Inc (NUTX) is 0.00, compared to its 5-year average forward P/E of -23.41.

Forward P/E

Fair
5Y Average P/E
-23.41
Current P/E
0.00
Overvalued
72.87
Undervalued
-119.68

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
50.16
Current EV/EBITDA
2.63
Overvalued
151.33
Undervalued
-51.01

Forward P/S

Fair
5Y Average P/S
2.71
Current P/S
1.43
Overvalued
9.29
Undervalued
-3.86

Alphio AI Price Scenarios for NUTX

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%NUTX

$429.67

Scenario price

B

Base

Base · 50%NUTX

$391.67

Scenario price

B

Bear

Bear · 25%NUTX

$341.69

Scenario price

Whales holding NUTX

D

Divisadero Street Capital Management, LP

+ HoldingNUTX

-14.88%

3M Return

Events Timeline

2026-09-22 (ET)

19:00:00

Nutex Health Approved for Dual Listing on Nasdaq Texas

2026-04-30 (ET)

17:20:00

Nutex Health Reports Q1 Revenue of $216.49M

2026-03-06 (ET)

09:00:00

Oil Prices Surge as Markets Decline Due to Geopolitical Risks

08:10:00

Nutex Health Reports $11.8M Net Income for Q4 2025

2026-03-05 (ET)

19:30:00

Marvell Technology Shares Rise 15% After Earnings

News

NUTX FAQ — answered by Alphio AI

Nutex Health Inc. is a healthcare management and operations company. The Company operates in three segments: the Hospital division, the Population Health Management (PHM) division, and the Real Estate division. The Hospital division owns, develops and operates healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates over 27 facilities in 12 states. In addition, it has financial and operating relationships with multiple professional entities and real estate entities. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). Through its Management Services Organization, it provides management, administrative and other support services to its affiliated hospitals and physician groups. The Real Estate division comprises the Real Estate Entities, which owns the land and hospital buildings which are leased to its hospital entities. It operates in the Healthcare sector (SERVICES-BUSINESS SERVICES, NEC industry).

Nutex Health Inc is a good buy right now due to its strong recent performance, including a net income of $65.8 million in Q2 2026 and an EPS of $9.38, which is a substantial improvement from a loss in the same quarter last year. The current price is $186.10, and analysts have set price targets as high as $325, suggesting an upside of over 74%. However, the company is facing risks from a recent cybersecurity incident that could impact investor confidence, which is a significant concern.

Community

More ↗
0xDawnbridge9/11/2026

$NUTX I've never seen a stock fight so hard to clear resistance at $200. It's coming, and the beach ball will burst up after being held underwater.

Show more
Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading